Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Clavis Tests Lipid Vector Program With Trial Of Cytarabine Derivative

Feb. 26, 2003

By Cormac Sheridan

Clavis Tests Lipid Vector Program With Trial Of Cytarabine Derivative

Feb. 26, 2003

By Cormac Sheridan

PhotoCure Seeks U.S. Approval Of Basal Cell Carcinoma Therapy

Feb. 26, 2003

By Cormac Sheridan

Active Biotech Seeks $26.5M In Discounted Rights Offering

Feb. 19, 2003

By Cormac Sheridan

Investment Rules Delay First Closing Of New Nordic Fund

Feb. 19, 2003

By Cormac Sheridan

Active Biotech Seeks $26.5M In Discounted Rights Offering

Feb. 19, 2003

By Cormac Sheridan

Investment Rules Delay First Closing Of New Nordic Fund

Feb. 19, 2003

By Cormac Sheridan

IsoTis Receives EU Approval Of Synthetic Bone Substitute

Feb. 12, 2003

By Cormac Sheridan

IsoTis Receives EU Approval Of Synthetic Bone Substitute

Feb. 12, 2003

By Cormac Sheridan

Sophion Raises $5M To Fund Automated Patch Clamp System

Feb. 5, 2003

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...